TherapeuticsMD Overview
Update this profile
Share Price
$9.29
(As of Friday Closing)
TherapeuticsMD General Information
Description
TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.
Contact Information
TherapeuticsMD Timeline
Financing Round Captured Employee Count Estimated Employee Growth
Want to dig into this profile?
We’ll help you find what you need
Learn more
TherapeuticsMD Stock Performance
(As of Friday Closing)
Stock Price
Previous Close
52 wk Range
Market Cap
Shares
Average Volume
EPS
$9.29
$8.90
$1.99 - $49.00
$87.1M
9.4M
1.52M
-$21.69
TherapeuticsMD Financials Summary
In Thousands, USD
TTM
31-Mar-2022
FY 2021
31-Dec-2021
FY 2020
31-Dec-2020
FY 2019
31-Dec-2019
EV
297,274
241,185
531,446
706,022
Revenue
86,418
86,951
64,872
49,647
EBITDA
(157,367)
(145,747)
(153,408)
(158,227)
Net Income
(182,053)
(172,415)
(183,524)
(176,145)
Total Assets
133,381
169,472
181,610
265,986
Total Debt
212,123
197,693
248,627
205,281
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
TherapeuticsMD Valuation & Funding
Deal Type
Date
Amount
Valuation/ EBITDA
Post-Val
Status
Debt
This information is available in the PitchBook Platform. To explore TherapeuticsMD‘s full profile, request access.
Request a free trial
TherapeuticsMD Comparisons
Description
Primary Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusiv
Pharmaceuticals
Boca Raton, FL
309
As of 2022
00000
000000000
00000
olor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore mag
000000000000000
Herndon, VA
ore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
0000 000000000
Henderson, NV
000
As of 0000
00000
000000 - 000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trial
TherapeuticsMD Competitors (6)
Company Name
Financing Status
Location
Employees
Total Raised
Last Financing Date/Type
Last Financing Amount
Ascend Therapeutics (Besins Healthcare)
Corporation
Herndon, VA
00000000 000000000
Corporation
Henderson, NV
000
00000
000000 - 000
00000
0000000 0000000000
Formerly VC-backed
South San Francisco, CA
000
00000
000000&0
00000
000000000000000 00
Corporation
Lagos, Nigeria
00
00000000 000000000
Formerly PE-Backed
Orlando, FL
000
000000&0
To view TherapeuticsMD’s complete competitors history, request access »
TherapeuticsMD Patents
255
Total Documents
Applications and Grants
000
Total Patents
Families
20
Granted
7
Pending
000
Expiring
in next 12 mo
TherapeuticsMD Recent Patent Activity
Publication ID
Patent Title
Status
First Filing Date
Technology (CPC)
Citations
US-20210244747-A1
Steroid hormone pharmaceutical formulations
Pending
07-Feb-2020
0000000000
US-20190022107-A1
Vaginal inserted estradiol pharmaceutical compositions and methods
Abandoned
08-Jun-2017
0000000000
AU-2018280270-A1
Vaginal inserted estradiol pharmaceutical compositions and methods
Pending
08-Jun-2017
0000000000
US-20180280410-A1
Natural combination hormone replacement formulations and therapies
Abandoned
03-Apr-2017
0000000000
US-20190247401-A1
Natural combination hormone replacement formulations and therapies
Abandoned
03-Apr-2017
A61K31/566
To view TherapeuticsMD’s complete patent history, request access »
TherapeuticsMD Executive Team (19)
Update this profile
Name
Title
Board Seat
Contact Info
Hugh O'Dowd
Chief Executive Officer & Board Member
John Milligan IV
Chief Executive Officer
Michael Donegan
Interim Chief Financial Officer, Chief Accounting Officer and Vice President of Finance
Mitchell Krassan
Executive & Chief Strategy Officer, Strategy
John Knighton
Chief Compliance Officer
You’re viewing 5 of 19 executive team members. Get the full list »
TherapeuticsMD Signals
Growth Rate
0.80%
Weekly Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial
TherapeuticsMD Investors
Investor Name
Investor Type
Holding
Investor Since
Participating Rounds
Contact Info
This information is available in the PitchBook Platform. To explore TherapeuticsMD‘s full profile, request access.
Request a free trial
TherapeuticsMD
Acquisitions (3)
Company Name
Deal Date
Deal Type
Deal Size
Industry
Lead Partner
000000000
04-Oct-2011
0000000000
00.000
Biotechnology
000000 00
00000000 0000
11-Jun-2010
0000000000
00000
Other Healthcare Services
Croff Enterprises
27-Jul-2009
Merger/Acquisition
000.00
Holding Companies
To view TherapeuticsMD’s complete acquisitions history, request access »